Brief: Mustang Bio Announces Initial Phase 1 Data On MB-105 For Patients With PSCA-Positive Castration Resistant Prostate Cancer

Mustang Bio

26/10/2020 12:21

Oct 26 (Reuters) - Mustang Bio Inc  MBIO.O :
    * MUSTANG BIO ANNOUNCES INITIAL PHASE 1 DATA ON MB-105 FOR
PATIENTS WITH PSCA-POSITIVE CASTRATION RESISTANT PROSTATE CANCER
    * MUSTANG BIO INC - ANTICIPATE PROVIDING FURTHER DATA IN
SECOND
HALF OF 2021
    * MUSTANG BIO INC - MB-105 DEMONSTRATED ON DAY 28, 94 %
REDUCTION
IN PROSTATE-SPECIFIC ANTIGEN IN ONE PATIENT
    * MUSTANG BIO INC - NEAR COMPLETE REDUCTION OF MEASURABLE
SOFT
TISSUE METASTASIS AND IMPROVEMENT IN BONE METASTASES IN ONE
PATIENT

Source text for Eikon:  ID:nGNX2K4r6q 
Further company coverage:  MBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))